Gate2Brain raises $7.5M (Spain, Jun 2026)
Reach the investors backing rounds like this
Backed by Shilpa Biocare Pvt Ltd · verified emails and LinkedIn on Datapile
Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate - EU-Startups
Gate2Brain is a Spanish biotech company focused on developing therapeutic candidates for aggressive pediatric and adult brain tumors. The company aims to address high unmet medical needs in central nervous system diseases by enabling therapeutics to cross the blood-brain barrier using its proprietary technology platform.
Barcelona-based Gate2Brain secures €7 million to advance brain tumour candidate EU-Startups
| Jul 27, 2026 | Multiverse Computing | $570.0M | Series C | Spain |
| Jun 17, 2026 | NeuralTrust | $20.0M | Seed | Spain |
| Jun 15, 2026 | Orbio | $21.0M | Series A | Spain |
| Jun 11, 2026 | THEKER | $78.0M | Series A | Spain |
5,238 investors back startups in Spain
You just read who funded Gate2Brain. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.